Olive Oil Revolutionizes COVID-19 Vaccine, CRISPR Gene Editing, and Cancer Treatments

Olive oil is one of the most useful elements of people ‘pantry. In addition to being a common ingredient for many recipes, it also offers health benefits, including improving heart health and reduction in inflammation. Now, the secret of olive oil to anti-inflammation can be found in an unexpected place: your next COVVI-19 vaccine.

A new study, published in Biomedical engineering of natureused the anti-inflammatory properties of olive oil to inspire a new type of mRNA vaccine. These vaccines are not only less painful but also more effective and more durable.

How did scientists achieve this breakthrough? By a slight adjustment of the lipid nanoparticles of vaccines (LNP), which deliver mRNA to the body.

“By essentially changing the recipe for these lipids, we were able to make them better with fewer side effects. He is a winner winner,” said Michael J. Mitchell, associate professor in bio-engineering and the main author of the newspaper, in a press release.

This newly created LNP – known as C -A16 – has the potential to revolutionize the delivery of vaccines, the editing of CRISPR genes and even cancer treatments.

Learn more:: Seed oils or animal fats: what is the healthiest to cook?

Create a less painful vaccine

To find this scientific breakthrough in the present, the research team had to start in the past.

Normally, ionizable lipids In LNP, are made using a sandwich type method where chemical reactions brings together two distinct components to create a new molecule. This method has had incredible success and has not led many scientists to study new or different methods for this process.

However, this group of scientists decided to determine if other processes were possible and, potentially, more effective. They found their response in a centenary method known as Mannich’s reaction, which combines three components rather than two. The addition of an additional component has considerably increased the number of molecular results.

Using Mannich’s reaction, the team created a library of hundreds of new lipids, one of them being C-A16. This lipid was created by adding a group of compounds commonly found in olive oil. During the tests, they were surprised to note that the addition of the compounds of olive oil led to a substantial decrease in inflammation. More importantly, the new LNP has also outperformed current mRNA vaccines on the market and has shown significant performance improvements.

“It’s a bit like secret sauce,” said Ninqiang Gong, co-first author of the newspaper, in the press release. “THE [compounds] Not only reduce the side effects associated with LNP, but improve their efficiency. »»

After making the new LNP, scientists used it in a COVVI-19 mRNM vaccine. In addition to being less painful, the vaccine created an immune response which was five times stronger than those currently available.

How C-A16 could revolutionize medicine

After seeing the anti-inflammatory and global effects of C-A16 performance, researchers were curious to know if their new LNP could be incorporated into other areas of medicine. The positive results were overwhelming.

To begin with, the C-A16 is promising to help the genes of genes of genes like Crispr. In a mouse test, the C-A16 helped publish a defective gene which causes a rare genetic liver disease, more than to double the effectiveness of current genes for genes.

In another animal trial, the team also tested the effectiveness of new LNPs in the supply of cancer treatment. Here, treatments against melanoma cancer delivered using C-A16 were three times more effective in reducing tumors and stimulated the destructive power of T cells that fight against cancer.

The research team behind the discovery hopes to find more secrets locked in chemical methods and the processes of the past.

“We tried to apply a discovery reaction a century ago, and we found that this could considerably improve advanced medical treatments. It is exciting to imagine what remains to be rediscovered with others,” Mitchell said in the press release.

This article does not offer medical advice and should be used for information purposes only.

Learn more:: CRISPR holds its promise with a first personalized gene editing therapy

Article Sources

Our writers at Discovermagazine.com Use studies evaluated by high -quality peers and sources for our articles, and our publishers examine scientific precision and editorial standards. Review the sources used below for this article:

As a Marketing Coordinator of Discover magazine, Stephanie Edwards interacts with readers through the social networks of Discover and writes digital content. Offline, she is responsible for courses in English and cultural studies at Lakehead University, by teaching lessons on everything, from professional communication to Taylor Swift, and obtained her graduate diplomas in the same department of McMaster University. You can find more of its scientific writing in the laboratory and its short fiction in anthologies and the literary magazine through the kind of horror.